GammaDelta Therapeutics announced as winner of the 2018 Outstanding Achievement Award at the OBN Annual Awards Ceremony.

Peter Goodfellow, DPhil

Chairman of the Board

Peter Goodfellow is a Science Advisor and Consultant for Abingworth, Sanofi and the Bill and Melinda Gates Foundation. He was previously the Balfour Professor of Genetics at Cambridge University before working for SmithKline Beecham (later GSK) as Head of Research. He has founded several biotechnology companies and has sat on the Boards of Prosensa Holdings N.V., deCode, GenSight Biologics and medical charities. Peter holds doctorates from Oxford and Bristol Universities and is a Fellow of EMBO, the Academy of Medical Sciences and the Royal Society.